Hyaluronic acid (hyaluronan): A review

Veterinarni Medicina

Volumn 53, Issue 8, 2008, Pages 397-411

  Necas, Jiri ^a   Bartosikova, L ^a   Brauner, P ^b   Kolar, J ^b  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b UNIVERSITY OF VETERINARY AND PHARMACEUTICAL SCIENCES   (Czech Republic)

Author keywords

Hyaluronic acid; Metabolism; Toxicity

Indexed keywords

ANIMALIA; BACTERIA (MICROORGANISMS); BOVINAE;

EID: 51949096540     PISSN: 03758427     EISSN: None     Source Type: Journal    
DOI: 10.17221/1930-VETMED     Document Type: Article

References (73)

1. Ahrens T., Assmann V., Fieber C., Termeer C.C., Herrlich P., Hofmann M., Simon J.C. (2001): CD44 is the principal mediator of hyaluronic-acid-induced melanoma cell proliferation. Journal of Investigative Dermatology, 116, 93-101
2. Akmal M., Singh A., Anand A., Kesani A., Aslam N., Goodship A., Bentley G. (2005): The effects of hyaluronic acid on articular chondrocytes. Journal of Bone and Joint Surgery-British volume, 8, 1143-1149
3. Amarnath L.P., Srinivas A., Ramamurthi A. (2006): In vitro hemocompatibility testing of UV-modified hyaluronan hydrogels. Biomaterials, 27, 1416-1424
4. Antonas K.N., Fraser J.R.E., Muirden K.D. (1973): Distribution of biologically labelled hyaluronic acid injected into joints. Annals of Rheumatic Diseases, 32, 103-111
5. Balazs E.A., Denlinger J.L. (1984): The role of hyaluronic acid in arthritis and its therapeutic use. In: Peyron J.G. (ed.): Osteoarthritis: Current Clinical and Fundamental Problems. Geigy, Basle Geigy. 165-174
6. Balazs E.A., Denlinger J.L (1989): Clinical uses of hyaluronan. Ciba Found Symposium, 143, 265-275
7. Balazs E.A., Laurent T.C., Jeanloz R.W. (1986): Nomenclature of hyaluronic acid. Biochemical Journal, 235, 903
8. Banerji S., Ni J., Wang S.X., Clasper S., Su J., Tammi R., Jones M., Jackson D.G. (1999): LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. The Journal of Cell Biology, 4, 789-801
9. Barbucci R., Magnani A., Casolaro M., Marchettini N., Rosi C., Bosco M. (1995): Modification of hyaluronic acid by insertion of sulfate groups to obtain a heparin-like molecule. Part I. Characterization and behavior in aqueous solution towards H+ and Cu2+ ions. Gazzetta Chimica Italiana, 125, 169-180
10. Barbucci R., Lamponi S., Borzacchiello A., Ambrosio L., Fini M., Torricelli P., Giardino R. (2002): Hyaluronic acid hydrogel in the treatment of osteoarthritis. Biomaterials, 23, 4503-4513
11. Bentsen K.D., Henriksen J.H., Boesby S., Horstev-Petersen K., Lorenzen I. (1989): Hepatic and renal excretion of circulating type III procollagen amino-terminal propeptide and hyaluronan in pig. Journal of Hepatology, 9, 177-183
12. Brown M.B., Jones S.A. (2005): Hyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skin. Journal of European Academy of Dermatology and Venereology, 19, 308-318
13. Camenisch T.D., Spicer A.P., Brehm-Gibson T., Biesterfeldt J., Augustine M.L., Calabro A. Jr., Kubalak S., Klewer S.E., McDonald J.A. (2000): Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. Journal of Clinical Investigation, 106, 349-360
14. Chen W.Y.J., Abatangelo G. (1999): Functions of hyaluronan in wound repair. Wound Repair and Regeneration, 7, 79-89
15. Cowman M.K., Matsuoka S. (2005): Experimental approaches to hyaluronan structure. Carbohydrate Research, 340, 791-809
16. Dechert T.A., Ducale A.E., Ward S.I., Yager D.R. (2006): Hyaluronan in human acute and chronic dermal wounds. Wound Repair and Regeneration, 14, 252-258
17. Ding M., Danielsen C.C., Hvid I. (2005): Effects of hyaluronan on three-dimensional microarchitecture of subchondral bone tissues in guinea pig primary osteoarthrosis. Bone, 36, 489-501
18. Echigo R., Mochizuki M., Nishimura R., Sasaki N. (2006): Suppressive effect of hyaluronan on chondrocyte apoptosis in experiment induced acute osteoarthritis in dog. Journal of Veterinary Medical Sciences, 68, 899-902
19. Forsberg N., Von Malmborg N., Madsen K., Rolfsen W., Gustafson S. (1994): Receptors for hyaluronan on corneal endotelial cells. Experimental Eye Research, 59, 689-696
20. Fraser J.R.E., Laurent T.C., Pertoft H., Baxter E. (1981): Plasma clearance, tissue distribution and metabolism of hyaluronic acid injected intravenously in the rabbit. Biochemical Journal, 200, 415-424
21. Gerwin N., Hops C., Lucke A. (2006): Intraarticular drug delivery in osteoarthritis. Advanced Drug Delivery Reviews, 58, 226-242
22. Girish K.S., Kemparaju K. (2006): Inhibition of Naja naja venon hyaluronidase: Role in the management of poisonous bite. Life Sciences, 87, 1433-1440
23. Hajjaji H.E., Cole A.A., Manicourt D.H. (2005): Chondrocytes, synoviocytes and dermal fibroblasts all express PH-20, a hyaluronidase active at neutral pH. Arthritis Research and Therapy, 7, R756-R768
24. Hascall V.C., Majors A.K., de la Motte C.A., Evanko S.P., Wang A., Drazba J.A., Strong S.A., Wight T.N. (2004): Intracellular hyaluronan: a new frontier for inflammation? Biochimica and Biophysica Acta, 1673, 3-12
25. Hill A., McFarlane S., Johnston P.G., Waugh D.J.J. (2006): The emerging role of CD44 in regulating skeletal micrometastasis. Cancer Letters, 237, 1-9
26. Iacob S., Knudson C.B. (2006): Hyaluronan fragments activate nitric oxide synthase and the production of nitric oxide by articular chondrocytes. The International Journal of Biochemistry and Cell Biology, 38, 123-133
27. Jansen K., van der WerffJ.F.A., van Wachem P.B., Nicolai J.P.A., de Leij L.F.M.H., van Luyn M.J.A. (2004): A hyaluronan-based nerve guide: in vitro cytotoxicity, subcutaneous tissue reactions, and degradation in the rat. Biomaterials, 25, 483-489
28. Jaracz S., Chen J., Kuznetsova L.V., Ojima I. (2005): Recent advances in tumor-targeting anticancer drug conjugates. Bioorganic and Medicinal Chemistry, 13, 5043-5054
29. Kahmann J.D., O'Brien R., Werner J.M., Heinegard D., Ladbury J.E., Campbell I.D., Day A.J. (2000): Localization and characterization of the hyaluronan-binding site on the Link module from human TSG-6. Structure, 8, 763-774
30. Karjalainen J.M., Tammi R.H., Tammi M.I., Eskelinen M.J., Agren U.M., Parkkinen J.J., Alhava E.M., Kosma V.M. (2000): Reduced level of CD44 and hyaluronan associated with unfavorable prognosis in clinical stage I cutaneous melanoma. American Journal of Pathology, 157, 957-965
31. Kim C.H., Lee B.J., Yoon J., Seo K.M., Lee J.W., Choi E.S., Hong J.J., Lee Y.S., Park J.H. (2001): Therapeutic effect of hyaluronic acid on experimental osteoarthrosis of ovine temporomandibular joint. Journal of Veterinary Medical Sciences, 63, 1083-1089
32. Kim E., Baba D., Kimura M., Yamashita M., Kashiwabara S., Baba T. (2005): Identification of a hyaluronidase, Hyal5, involved in penetration of mouse sperm through cumulus mass. Proceedings of the National Academy of Sciences of the United States of America, 50, 18028-18033
33. Kosaki R., Watanabe K., Yamaguchi Y. (1999): Overproduction of hyaluronan by expression of the hyaluronan synthase Has2 enhances anchorage-independent growth and tumorigenicity. Cancer Research, 59, 1141-1145
34. Kreil G. (1995): Hyaluronidases-A group of neglected enzymes. Protein Sciences, 4, 1666-1669
35. Laurent T.C. (1989): The biology of hyaluronan. In: Ciba Foundation Symposium 143. John Wiley and Sons, New York. 1-298
36. Laurent T.C., Fraser J.R.E. (1992): Hyaluronan. FASEB Journal, 6, 2397-2404
37. Laurent U.B.G., Reed R.K. (1991): Turnover of hyaluronan in the tissues. Advanced Drug Delivery Reviews, 7, 237-256
38. Leach J.B., Schmidt C.E. (2004): Hyaluronan. Encyclopedia of Biomaterials and Biomedical Engineering. Marcel Dekker, New York. 779-789
39. Lebel L. (1991): Clearance of hyaluronan from the circulation. Advanced Drug Delivery Reviews, 7, 221-235
40. Lee J.Y., Spicer A.P (2000): Hyaluronan: a multifunctional, megaDalton, stealth molecule. Current Opinion in Cell Biology, 12, 581-586
41. Lim Y.J., Sim W.S., Kim Y. Ch., Lee S. Ch., Choi Y.L. (2003): The neurotoxicity of epidural hyaluronic acid in rabbits: A light and electron microscopic examination. Anesthesia and Analgesia, 97, 1716-1720
42. Lin G., Stern R. (2001): Plasma hyaluronidase (Hyal-1) promotes tumor cell cycling. Cancer Letters, 163, 95-101
43. Liu N., Gao F., Han Z., Xu X., Underhill Ch. B., Zhang L. (2001): Hyaluronan synthase 3 overexpression promotes the growth of TSU prostate cancer cells. Cancer Research, 61, 5207-5214
44. Lokeshwar V.B., Schroeder G.L., Carey R.I., Soloway M.S., Iida N. (2002): Regulation of hyaluronidase activity by alternative mRNA splicing. Journal of Biological Chemistry, 277, 33654-33663
45. McKee C.M., Penno M.B., Cowman M., Burdick M.D., Strieter R.M., Bao C., Noble P.W. (1996): Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. Journal of Clinical Investigation, 98, 2403-2413
46. Medina J.M., Thomas A., Denegar C.R. (2006): Knee osteoarthritis: Should your patient opt for hyaluronic acid injection? Journal of Family Practice, 8, 667-675
47. Meyer K., Palmer J.W. (1934): The polysaccharide of the vitreous humor. Journal of Biology and Chemistry, 107, 629-634
48. Mio K., Stern R. (2002): Inhibitors of the hyaluronidases. Matrix Biology, 21, 31-37
49. Moreland L.W. (2003): Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action. Arthritis Research and Therapy, 5, 54-67
50. Nawrat P., Surazynski A., Karna E., Palka J.A. (2005): The effect of hyaluronic acid on interleukin-1-induced deregulation of collagen metabolism in cultured human skin fibriblasts. Pharmacological Research, 51, 473-477
51. Neo H., Ishimaru J.I., Kurita K., Goss A.N. (1997): The effect of hyaluronic acid on experimental temporomandibular joint osteoarthrosis in the sheep. Journal of Oral Maxillofacial Surgery, 55, 1114-1119
52. Noble P.W. (2002): Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biology, 21, 25-29
53. Oertli B., Fan X., Wuthrich R.P. (1998): Characterization of CD44-mediated hyaluronan binding by renal tubular epithelial cells. Nephrology Dialysis Transplantation, 13, 271-278
54. Paiva P., Van Damme M.P., Tellbach M., Jones R.L., Jobling T., Salamonsen L.A. (2005): Expression patterns of hyaluronan, hyaluronan synthases and hyaluronidases indicate a role for hyaluronan in the progression of endometrial cancer. Gynecologic Oncology, 98, 193-202
55. Pohl M., Sakurai H., Stuart R.O., Nigam S.K. (2000): Role of hyaluronan and CD44 in in vitro branching morphogenesis of ureteric bud cells. Developmental Biology, 224, 312-325
56. Ponnuraj K., Jedrzejas M. (2000): Mechanism of hyaluronan binding and degradation: Structure of Streptococcus pneumoniae hyaluronate lyase in complex with hyaluronic acid disaccharide at 1.7 Å resolution. Journal of Molecular Biology, 299, 885-895
57. Product information. Orthovisc®, Summary of safety and effectiveness data. 2004, 1-15
58. Protin U., Schweighoffer T., Jochum W., Hilberg F. (1999): CD44-deficient mice develop normally with changes in subpopulations and recirculation of lymphocyte subsets1. The Journal of Immunology, 163, 4917-4923
59. Pure E., CuffC.A. (2001): A crucial role for CD44 in inflammation. Trends in Molecular Medicine, 7, 213-221
60. Roth A., Mollenhauer J., Wagner A., Fuhrmann R., Straub A., Venbrocks R.A., Petrow P., Brauer R., Schubert H., Ozegowski J., Peschel G., Muller P.J. (2005): Intra-articular injections of high-molecular-weight hyaluronic acid have biphasic effects on joint inflammation and destruction in rat antigen-induced arthritis. Arthritis Research and Therapy, 7, 677-686
61. Schmits R., Filmus J., Gerwin N., Senaldi G., Kiefer F., Kundig T., Wakeham A., Shahinian A., Catzavelos C., Rak J., Furlonger C., Zakarian A., Simard J.J.L., Ohashi P.S., Paige C.J., Gutierrez-Ramos J.C., Mak T.W (1997): CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood, 90, 2217-2233
62. Smedsrod B. (1991): Cellular events in the uptake and degradation of hyaluronan. Advanced Drug Delivery Reviews, 7, 265-278
63. Taylor K.R., Trowbridge J.M., Rudisill J.A., Termeer C.C., Simon J.C., Gallo R.L. (2004): Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. Journal of Biological Chemistry, 279, 17079-17084
64. Toole B.P. (1997): Hyaluronan in morphogenesis. Journal of Internal Medicine, 242, 35-40
65. Toole B.P. (2001): Hyaluronan in morphogenesis. Cell and Developmental Biology, 12, 79-87
66. Toole B.P., Wight T.N., Tammi M.I. (2002): Hyaluronan-cell interactions in cancer and vascular disease. Journal of Biological Chemistry, 277, 4593-4596
67. Turley E.A., Noble P.W., W. Bourguignon L.Y. (2002): Signaling properties of hyaluronan receptors. Journal of Biological Chemistry, 277, 4589-4592
68. Tzircotis G., Thorne R.F., Isacke C.M. (2005): Chemotaxis towards hyaluronan is dependent on CD44 expression and modulated by cell type variation in CD44-hyaluronan binding. Journal of Cell Science, 118, 5119-5128
69. Underhill C. (1992): CD44: The hyaluronan receptor. Journal of Cell Sciences, 103, 293-298
70. Uthman I., Raynauld J.P., Haraoui B. (2003): Intra-articular therapy in osteoarthritis. Postgradual Medicine Journal, 79, 449-453
71. Wang C.T., Lin J., Chang C.J., Lin Y.T., Hon S.M. (2004): Therapeutics effects of hyaluronic acid on osteoarthritis of the knee. The Journal of Bone and Joint Surgery-American Volume, 3, 538-545
72. Weigel J.A., Raymond R.C., Weigel P.H. (2002): The hyaluronan receptor for endicytosis (HARE) is not CD44 or CD54 (ICAM-1). Biochemical and Biophysical Research Communications, 294, 918-922
73. Wen D.Y. (2000): Intra-articular hyaluronic acid injections for knee osteoarthrosis. American Family Physician, 62, 565-570